Key Highlights
- KARL STORZ, a leading MedTech company, acquires Innersight Labs Ltd. (ISL), an innovative software manufacturer specializing in 3D medical modeling.
- The acquisition introduces cutting-edge AI technology to KARL STORZ’s portfolio, promising to improve surgical outcomes with advanced 3D models from medical scans.
- Close collaboration anticipated between KARL STORZ’s robotics subsidiary, VentureOne, and ISL to enhance robotic medical products.
Source: Business Wire
Notable Quotes
- “The development of our robotic products will benefit enormously from ISL’s knowledge with regard to the use of AI. We are therefore very much looking forward to the cooperation and to further growing together in this area,” – Stephan Abele, Managing Director at KARL STORZ VentureOne
- “We want to continue pioneering MedTech, particularly in the areas of software and robotics. The research background that ISL brings to the table therefore fits ideally with our vision, mission, and strategic goals. We warmly welcome them to the KARL STORZ family,” – Thorsten Molitor, Executive Vice President at KARL STORZ
SoH's Take
This acquisition marks a significant milestone in the MedTech industry. By integrating Innersight Labs’ AI-driven 3D modeling capabilities, KARL STORZ is set to redefine surgical precision and effectiveness. This move not only enhances their existing endoscopic and medical device solutions but also underscores their commitment to innovation and excellence in medical technology. With a focus on reducing surgical risks and operation times, this collaboration promises a new era of technological advancements in medical imaging and robotics, solidifying KARL STORZ’s position as a pioneer in the MedTech sector.
